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Introduction: Leukocyte-cell derived chemotaxin 2 (LECT2), fibroblast 
growth factor 21 (FGF21) and fetuin-A are liver-derived proteins (hepa-
tokines) which can influence substrate metabolism and insulin sensitiv-
ity. Hepatokines are modulated by chronic energy status and associated 
metabolic disease; however less in known about their sensitivity to acute 
nutrient and energy manipulation. This study explored the influence of 
hyper-energetic, high-fat feeding on circulating hepatokine concentra-
tions and examined the time-course of these responses.
Methods: In a randomised, counterbalanced, crossover design, 12 healthy 
men (mean ± SD: age, 24 ± 4 years; BMI, 24.1 ± 1.5 kg/m²) completed 
two seven-day diets separated by a three-week washout period: a hyper- 
energetic, high-fat diet (HE-HFD; +50% excess energy, 65% fat) and a 
control (habitual) diet. Before (baseline) and after each diet, whole-body 
insulin sensitivity was assessed during an oral glucose tolerance test us-
ing the Matsuda Insulin Sensitivity Index; whilst body fat percentage was 
measured via bioelectrical impedance analysis. Fasting venous blood 
samples were obtained at baseline and after 1, 3 and 7 d of each diet for 
measurement of plasma LECT2, FGF21, fetuin-A, glucose, insulin, tria-
cylglycerol, non-esterified fatty acids, and the homeostatic model assess-
ment of insulin resistance (HOMA-IR).
Results: Anthropometric and metabolic responses to the diets are shown 
in Table 1. Compared with control, body mass and BMI tended to increase 
(both P ≤ 0.057) after the HE-HFD. HOMA-IR was significantly increased 
after 3 d of the HE-HFD compared to the control diet, whilst whole-body 
insulin sensitivity was reduced by 31% after 7 d (both P ≤ 0.021). Fasting 
plasma LECT2 concentrations were significantly higher than control after 
both 3 and 7 d of the HE-HFD (both P ≤ 0.004; Fig. 1A). Furthermore, 
fasting plasma FGF21 was significantly higher after 1 d (P = 0.008) and 
tended to be higher after 3 d of the HE-HFD (P = 0.040, NS after Bon-
ferroni adjustment; Fig 1B); whilst fasting plasma fetuin-A tended to be 
higher after 7 d of the HE-HFD (P = 0.028, NS after Bonferroni adjust-
ment; Fig. 1C).
Conclusion: This study demonstrates that in conjunction with impair-
ments to whole-body insulin sensitivity and fasting glucose metabolism, 
acute hyper-energetic, high-fat feeding modulates circulating hepatokines 
in humans. Specifically, both circulating LECT2 and FGF21 are increased 
rapidly (within 1-3 days) in response to overnutrition; however the FGF21 
response appears to diminish after seven days. Subtle increases in circu-
lating fetuin-A may also begin to occur after seven days of high-fat over-
feeding. 
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Tab. 1. Anthropometric and metabolic responses during the seven-day 
control and hyper-energetic, high-fat diets.
Diet BL 1 d 3 d 7 d
Anthropometric 
responses
Body mass (kg) Control diet 77.1 ± 4.3 - - 77.1 ± 4.3
HE-HFD 76.8 ± 3.7 - - 78.0 ± 4.1#
BMI (kg/m^2) Control diet 24.2 ± 1.6 - - 24.2 ± 1.6
HE-HFD 24.1 ± 1.5 - - 24.5 ± 1.5#
Body fat (%) Control diet 13.5 ± 3.8 - - 13.3 ± 3.8
HE-HFD 13.9 ± 3.1 - - 13.8 ± 3.2
Metabolic 
responses
Fasting glucose 
(mmol/L) Control diet 4.9 ± 0.4 4.8 ± 0.4 4.6 ± 0.4 4.8 ± 0.4
HE-HFD 4.8 ± 0.4 5.0 ± 0.3* 5.0 ± 0.5* 5.0 ± 0.3
Fasting insulin 
(pmol/L) Control diet 25 ± 12 28 ± 13 22 ± 9 23 ± 7
HE-HFD 27 ± 11 30 ± 8 30 ± 8 31 ± 11
Fasting TAG 
(mmol/L)
Control diet 0.75 ± 
0.19
0.76 ± 
0.19
0.74 ± 
0.20
0.86 ± 
0.29
HE-HFD 0.82 ± 0.16
0.63 ± 
0.20
0.57 ± 
0.16*
0.57 ± 
0.16*
Fasting NEFA 
(mmol/L) Control diet
0.37 ± 
0.13
0.30 ± 
0.12
0.33 ± 
0.16
0.32 ± 
0.13
HE-HFD 0.31 ± 
0.12
0.26 ± 
0.14
0.30 ± 
0.09
0.25 ± 
0.09
HOMA-IR Control diet 0.8 ± 0.4 0.9 ± 0.5 0.7 ± 0.3 0.7 ± 0.3
HE-HFD 0.8 ± 0.4 1.0 ± 0.3 1.0 ± 0.3* 1.0 ± 0.4
Matsuda ISI Control diet 15.1 ± 6.6 - - 17.1 ± 8.6
HE-HFD 15.0 ± 
6.3 - -
11.8 ± 
5.8*
Data are means ± SD. BL, baseline; HE-HFD, hyper-energetic, high-fat diet; 
BMI, body mass index; TAG, triacylglycerol; NEFA, non-esterified fatty acids; 
HOMA-IR, homeostatic model assessment of insulin resistance; ISI, insulin 
 sensitivity index. *Significantly different from control diet at the same time 
point (P < 0.05). #Tended to differ from control diet at the same time point  
(P < 0.06).
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